Navigation Links
Alexion Reports Third Quarter 2008 Results
Date:10/23/2008

Continued Strong Uptake of Soliris(R) in U.S. and Europe

Reported Net Sales of $76.5 Million Include Recognition of $5.3 Million for Prior Quarter Shipments

Company Revises Revenue Guidance Upward and Expense Guidance Downward, and Forecasts GAAP Profit in Full Year 2008

Pipeline Progress in Hematology, Oncology, Transplant, Neurology

Third Quarter 2008 Financial Highlights:

-- Soliris(R) (eculizumab) net product sales of $76.5 million in Q3 2008 consisted of $71.2 million in net product sales for shipments that occurred in Q3 plus recognition of $5.3 million from net product sales associated with the decision of certain government payors during Q3 to reimburse for Soliris shipments that occurred in previous quarters.

-- Q3 GAAP net income was $19.7 million, or $0.23 per diluted share, compared to a GAAP net loss of $20.1 million, or $0.27 net loss per share, in Q3 2007.

-- Q3 non-GAAP net income was $25.7 million, or $0.29 per diluted share, compared to a non-GAAP net loss of $14.0 million, or $0.19 net loss per share, in Q3 2007. Q3 2008 non-GAAP net income, excluding the recognition of $5.3 million from prior-quarter shipments would be $20.8 million, or $0.23 per diluted share.

CHESHIRE, Conn., Oct. 23 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company," Nasdaq: ALXN) today announced financial results for the quarter ended September 30, 2008.

Third Quarter 2008 Financial Results:

For the three months ended September 30, 2008, Alexion reported total revenues of $76.5 million from net product sales of Soliris(R) (eculizumab), compared to total revenues of $21.8 million for the same period in 2007. The Q3 2008 revenues consisted of $71.2 million of net product sales from Soliris shipments during Q3, plus recognition of $5.3 million from net product sales associated with the Q3 2008 decision of certain government payors to reimburse for past Soliris shipment
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Alexion to Present at Bear Stearns Healthcare Conference
2. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
3. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
4. Alexion Reports Fourth Quarter and Full Year 2007 Results
5. Alexion Reports First Quarter 2008 Results
6. Notice of Time Change for Alexions Presentation at the Bank of America 2008 Health Care Conference
7. Alexion to Present at the William Blair 28th Annual Growth Stock Conference
8. Alexion to Present at the Jefferies & Co. 2nd Annual Healthcare Conference
9. Alexion Pharmaceuticals Invites You to Participate in its Second Quarter 2008 Results Conference Call and Web Cast
10. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Research presented at the 2015 AACC ... the studies that led to a fingerprick Ebola test ... disease to receive approval from the World Health Organization ... grip on West Africa by ... workers to isolate and treat these patients much faster ...
(Date:7/27/2015)... , July 27, 2015 Junto Health, a ... share information and develop new technology solutions, today announced ... Group (SPG), a leader in health care policy consulting. ... engage in a collaborative innovation process while, at the ... trends in public policy, health care finance and the ...
(Date:7/25/2015)... ... , ... Technology leader Anton Paar offers the Abbemat ... temperature of the measuring prism. This is required to achieve the most precise ... key requirements. It is likely that no refractometer manufacturers on the market can ...
(Date:7/24/2015)... N.J. , July 24, 2015  Champions Oncology ... advanced technology solutions and services to personalize the development ... report its financial and operational results for the fourth ... on Tuesday, July 28, 2015, before market open. ... discuss the results that day at 9:00 a.m. EDT ...
Breaking Biology Technology:Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2
... , ,MADISON Speaking at the Bionanotechnology conference ... a long view of the science and industry behind making ... but lackluster in innovation. , ,Steve Crosby, editor of ... to know: the magazine has worked with the National ...
... todays dynamic technology space is a challenge for ... to help Wisconsins businesses and government bound over ... technology and RFID implementation. , ,The Government ... in Madison is examining the aspects of effectively ...
... Sonic Foundry Inc . has introduced two new ... rich media for a variety of uses. The ... rich media technology, are intended to enable customers ... for corporate communications, Web-based education, online training, product ...
Cached Biology Technology:Wisconsin places high in nanotech venture capital, average in innovation 2Sonic Foundry announces new Mediasite products 2
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, ... devices with specialties in single use solutions, headquartered in ... MedConx, Inc. (a California corporation with ... San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility in ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Sharp has selected ... secure authentication for its latest flagship smartphone device, ... than 200 million shipments of its fingerprint ID ... Synaptics, strength, scalability and leadership in the biometrics ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... Dynamic Gastric Model, developed from years of research at ... towards improving its commercial use by food and drug ... Plant Bioscience Limited (PBL) have secured funding from the ... develop the Dynamic Gastric Model to validate and improve ...
... for Research in Vision and Ophthalmology 2013 Annual Meeting ... Nobel laureates, during the organization,s five-day conference, May 5 ... the ARVO/Alcon Keynote Series will include Oliver Smithies, DPhil; ... Smithies, of the University of North Carolina at Chapel ...
... Ph.D., has won a BioMaryland LIFE Award, and Ronald Berger, ... the Abell Foundation, the researchers learned last week. Each of ... for clinical use. The prizes were awarded as ... Alliance for Science and Technology Development and the University of ...
Cached Biology News:Commercial future for Model Gut 23 distinguished keynote speakers to present during ARVO 2013 Annual Meeting 23 Johns Hopkins researchers recognized for medical inventions 23 Johns Hopkins researchers recognized for medical inventions 3
Contained in EZ-Tn5™ Kits and are available separately for sequencing of an insertion site....
... peptide derived from the N-terminal region of ... Specificity: Specific for the N-terminus of the ... Dog Rat Mouse (positive controls: MDCK-II A431 ... heart blood vessel and brain mossy fiber ...
Human Carnosine Dipeptidase 1 Affinity Purified PAb...
... Polyoxyethylene Lauryl Ether ... 0.02% Kathon Preservative. Surfactant. ... in immunohistochemistry is 1 ... 35 solution added to ...
Biology Products: